Agios Financial Statements From 2010 to 2026

Agios Pharm Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 869.3 M 1.3 B 759.9 M Slightly volatile Other Current Liabilities 34.6 M 45.5 M 29.9 M Slightly volatile Total Current Liabilities 77.2 M 82.2 M 69.3 M Slightly volatile Total Stockholder Equity 689.9 M 1.2 B 597.7 M Slightly volatile Other Liabilities 3.6 M 3.8 M 59.5 M Slightly volatile Property Plant And Equipment Net 52.4 M 41.2 M 45.3 M Slightly volatile Accounts Payable 15.7 M 18.4 M 13.7 M Slightly volatile Cash 84.7 M 89.1 M 213.2 M Pretty Stable Non Current Assets Total 231.8 M 355.2 M 199.8 M Slightly volatile Other Assets 4.8 M 4.5 M 2.1 M Slightly volatile Cash And Short Term Investments 631 M 854.4 M 553.8 M Slightly volatile Common Stock Total Equity 49.5 K 81.7 K 48 K Slightly volatile Common Stock Shares Outstanding 50.8 M 58 M 45.1 M Slightly volatile Short Term Investments 487.3 M 765.3 M 423.2 M Slightly volatile Liabilities And Stockholders Equity 869.3 M 1.3 B 759.9 M Slightly volatile Non Current Liabilities Total 20.8 M 21.9 M 88.2 M Very volatile Other Current Assets 26.4 M 44.1 M 23.4 M Slightly volatile Other Stockholder Equity 1.3 B 1.8 B 1.1 B Slightly volatile Total Liabilities 179.4 M 104.1 M 162.2 M Pretty Stable Property Plant And Equipment Gross 56.1 M 101.3 M 48.5 M Slightly volatile Total Current Assets 637.5 M 942.1 M 560.1 M Slightly volatile Short Term Debt 25.7 M 18.4 M 31 M Very volatile Common Stock 55.7 K 75 K 48.2 K Slightly volatile Property Plant Equipment 21.1 M 26.4 M 19.2 M Slightly volatile Net Tangible Assets 633.1 M 1.3 B 603 M Slightly volatile Net Receivables 6.9 M 10.6 M 7.1 M Pretty Stable Capital Surpluse 1.7 B 2.7 B 1.4 B Slightly volatile Deferred Long Term Liabilities 19.2 M 20.2 M 37.3 M Pretty Stable Long Term Investments 204.4 M 310 M 158.9 M Slightly volatile Non Current Liabilities Other 85.5 K 90 K 53.3 M Very volatile Net Invested Capital 982.8 M 1.2 B 685.4 M Slightly volatile Net Working Capital 759.8 M 859.8 M 554.6 M Slightly volatile Capital Stock 76.6 K 75 K 64.6 K Slightly volatile Short and Long Term Debt Total 67.7 M 62 M 99 M Slightly volatile Long Term Debt Total 538.4 K 605.7 K 661.1 K Slightly volatile Capital Lease Obligations 65.2 M 40.2 M 97.6 M Slightly volatile
Agios Pharm Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 7.9 M 5.2 M 6.8 M Slightly volatile Interest Expense 15.4 M 14.7 M 7.6 M Slightly volatile Selling General Administrative 95.1 M 180.3 M 82.3 M Slightly volatile Total Revenue 62.8 M 54 M 55.4 M Pretty Stable Other Operating Expenses 338 M 526.2 M 293.2 M Slightly volatile Research Development 242.9 M 339.5 M 210.9 M Slightly volatile Cost Of Revenue 6 M 6.3 M 60 M Slightly volatile Total Operating Expenses 333.4 M 519.8 M 289.3 M Slightly volatile Total Other Income Expense Net 107.7 M 58.3 M 92.7 M Slightly volatile Preferred Stock And Other Adjustments 3.3 M 3.7 M 4.1 M Slightly volatile Non Operating Income Net Other 35.5 M 33.8 M 13.4 M Slightly volatile Interest Income 59.2 M 56.4 M 15.5 M Slightly volatile Reconciled Depreciation 5.9 M 5.2 M 6.9 M Very volatile Discontinued Operations 1.6 B 1.8 B 1.9 B Slightly volatile
Agios Pharm Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Stock Based Compensation 43.1 M 52.6 M 37.1 M Slightly volatile Begin Period Cash Flow 109.5 M 76.2 M 98.9 M Slightly volatile Depreciation 6.6 M 5.2 M 5.7 M Slightly volatile Capital Expenditures 4.9 M 4.3 M 5.8 M Very volatile End Period Cash Flow 110.3 M 89.1 M 101.9 M Pretty Stable
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 33.73 29.207 48.909 Slightly volatile PTB Ratio 1.26 1.3226 5.5464 Slightly volatile Days Sales Outstanding 37.74 71.4556 40.5927 Slightly volatile Book Value Per Share 21.61 20.5809 12.2736 Slightly volatile Stock Based Compensation To Revenue 0.7 0.9727 1.112 Slightly volatile Capex To Depreciation 1.5 0.8337 1.4249 Slightly volatile PB Ratio 1.26 1.3226 5.5464 Slightly volatile EV To Sales 30.44 28.7053 44.8111 Slightly volatile Payables Turnover 0.33 0.3457 5.9269 Slightly volatile Sales General And Administrative To Revenue 1.56 1.49 1.1316 Slightly volatile Research And Ddevelopement To Revenue 4.38 6.2844 6.84 Slightly volatile Capex To Revenue 0.096 0.0799 0.1396 Pretty Stable Cash Per Share 9.51 14.7386 11.5009 Slightly volatile Days Payables Outstanding 1.1 K 1.1 K 1.2 K Slightly volatile Current Ratio 6.51 11.4597 7.8013 Slightly volatile Tangible Book Value Per Share 21.61 20.5809 12.2736 Slightly volatile Receivables Turnover 4.85 5.1081 18.2094 Slightly volatile Shareholders Equity Per Share 21.61 20.5809 12.2736 Slightly volatile Debt To Equity 0.0494 0.052 0.1422 Slightly volatile Capex Per Share 0.14 0.0744 0.1319 Pretty Stable Graham Net Net 14.03 13.3635 8.185 Slightly volatile Revenue Per Share 1.34 0.932 1.0949 Slightly volatile Interest Debt Per Share 1.61 1.0699 1.6985 Slightly volatile Debt To Assets 0.0859 0.0478 0.1048 Slightly volatile Graham Number 109 97.84 107 Slightly volatile Price Book Value Ratio 1.26 1.3226 5.5464 Slightly volatile Days Of Payables Outstanding 1.1 K 1.1 K 1.2 K Slightly volatile Company Equity Multiplier 1.75 1.0873 1.6844 Slightly volatile Long Term Debt To Capitalization 0.0144 0.0162 0.0176 Slightly volatile Total Debt To Capitalization 0.0469 0.0494 0.1218 Slightly volatile Debt Equity Ratio 0.0494 0.052 0.1422 Slightly volatile Quick Ratio 6.61 11.0592 7.91 Slightly volatile Cash Ratio 1.03 1.0842 2.9431 Pretty Stable Days Of Sales Outstanding 37.74 71.4556 40.5927 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 1.13 1.0116 1.0379 Pretty Stable Price To Book Ratio 1.26 1.3226 5.5464 Slightly volatile Fixed Asset Turnover 1.24 1.3104 3.1529 Slightly volatile Debt Ratio 0.0859 0.0478 0.1048 Slightly volatile Price Sales Ratio 33.73 29.207 48.909 Slightly volatile Asset Turnover 0.0396 0.0416 0.0823 Slightly volatile Price Fair Value 1.26 1.3226 5.5464 Slightly volatile
Agios Pharm Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 1.6 B 1.4 B 2 B Very volatile Enterprise Value 1.5 B 1.4 B 1.9 B Very volatile

Agios Fundamental Market Drivers

Agios Upcoming Events

About Agios Pharm Financial Statements

Pair Trading with Agios Pharm

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Agios Pharm position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agios Pharm will appreciate offsetting losses from the drop in the long position's value.When determining whether Agios Pharm offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Agios Pharm's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Agios Pharm Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Agios Pharm Stock:

How To Invest In Agios Details

Is Agios Stock a good investment? Details

What is Agios Pharm's Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details